Department of Emergency Medicine, Chungnam National University Hospital, Daejoen, Republic of Korea.
Department of Emergency Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
Neurocrit Care. 2021 Dec;35(3):815-824. doi: 10.1007/s12028-021-01241-0. Epub 2021 Jun 16.
This study aimed to compare day-specific associations of blood-brain barrier (BBB) disruption with neurological outcome in survivors of out-of-hospital cardiac arrest (OHCA) treated with target temperature management (TTM) and lumbar drainage.
This retrospective single-center study included 68 survivors of OHCA who underwent TTM between April 2018 and December 2019. The albumin quotient (Q) was calculated as Q = albumin/albumin immediately (day 1) and 24 (day 2), 48 (day 3), and 72 h (day 4) after the return of spontaneous circulation. The degree of BBB disruption was weighted using the following scoring system: Q value of 0.007 or less (normal), Q value greater than 0.007-0.01 (mild), Q value greater than 0.01-0.02 (moderate), and Q value greater than 0.02 (severe). Points were assigned as follows: 0 (normal), 1 (mild), 4 (moderate), and 9 (severe). Neurological outcome was determined at 6 months after the return of spontaneous circulation, as well as cerebral performance category (CPC), dichotomized as good (CPC score 1-2) and poor (CPC score 3-5) outcome.
We enrolled 68 patients (48 men, 71%); 37 (54%) patients had a poor neurological outcome. The distributions of poor versus good outcomes at 6 months in patients with moderate and severe BBB disruption were 19 of 22 (80%) vs. 18 of 46 (50%) on day 1, 31 of 37 (79%) vs. 6 of 31 (32%) on day 2, 32 of 37 (81%) vs. 5 of 31 (30%) on day 3, and 32 of 39 (85%) vs. 5 of 29 (30%) on day 4 (P < 0.001), respectively. Using receiver operating characteristic analyses, optimal cutoff values (sensitivity, specificity) of Q levels for the prediction of neurological outcome were as follows: day 1, greater than 0.009 (56.8%, 87.1%); day 2, greater than 0.012 (81.1%, 87.1%); day 3, greater than 0.013 (83.8%, 87.1%); day 4, greater than 0.013 (86.5%, 87.1%); the sum of all time points, greater than 0.039 (89.5%, 79.4%); and scoring system, greater than 9 (91.9%, 87.1%).
In this proof of concept study, Q was associated with poor neurological outcome in survivors of OHCA treated with TTM with no contraindication to lumbar drainage. A large multicenter prospective study is needed to validate the utility of BBB disruption as a prognosticator of neurological outcome.
本研究旨在比较目标温度管理(TTM)联合腰椎引流治疗院外心脏骤停(OHCA)幸存者中,不同时间点血脑屏障(BBB)破坏与神经结局的相关性。
本回顾性单中心研究纳入了 2018 年 4 月至 2019 年 12 月期间接受 TTM 的 68 例 OHCA 幸存者。白蛋白商(Q)的计算方法为:白蛋白/白蛋白即刻(第 1 天)和复流后 24(第 2 天)、48(第 3 天)和 72 小时(第 4 天)。BBB 破坏程度采用以下评分系统加权:Q 值为 0.007 或以下(正常)、Q 值为 0.007-0.01(轻度)、Q 值为 0.01-0.02(中度)和 Q 值大于 0.02(重度)。赋值如下:0(正常)、1(轻度)、4(中度)和 9(重度)。神经结局在复流后 6 个月时,以及脑功能状态分类(CPC)进行评估,分为良好(CPC 评分 1-2)和不良(CPC 评分 3-5)结局。
共纳入 68 例患者(48 例男性,71%);37 例(54%)患者存在不良神经结局。在中重度 BBB 破坏患者中,6 个月时不良与良好结局的分布分别为第 1 天为 22 例中的 19 例(80%)比 46 例中的 18 例(50%),第 2 天为 37 例中的 31 例(79%)比 31 例中的 6 例(32%),第 3 天为 37 例中的 32 例(81%)比 31 例中的 5 例(30%),第 4 天为 39 例中的 32 例(85%)比 29 例中的 5 例(30%)(P < 0.001)。使用受试者工作特征分析,Q 值预测神经结局的最佳截断值(敏感性、特异性)如下:第 1 天,大于 0.009(56.8%,87.1%);第 2 天,大于 0.012(81.1%,87.1%);第 3 天,大于 0.013(83.8%,87.1%);第 4 天,大于 0.013(86.5%,87.1%);所有时间点的总和,大于 0.039(89.5%,79.4%);评分系统,大于 9(91.9%,87.1%)。
在本概念验证研究中,Q 与 TTM 联合无腰椎引流禁忌证治疗的 OHCA 幸存者不良神经结局相关。需要进行大型多中心前瞻性研究,以验证 BBB 破坏作为神经结局预测因子的效用。